CVS KIDNEY CARE RXREVIEW Trademark
Trademark Overview
On Thursday, March 18, 2021, a trademark application was filed for CVS KIDNEY CARE RXREVIEW with the United States Patent and Trademark Office. The USPTO has given the CVS KIDNEY CARE RXREVIEW trademark a serial number of 90586801. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2023. This trademark is owned by CVS Pharmacy, Inc.. The CVS KIDNEY CARE RXREVIEW trademark is filed in the Advertising, Business and Retail Services category with the following description:
pharmaceutical cost management services and drug utilization review services for patients with complex or chronic medical conditions; providing healthcare operations management services for healthcare providers, namely, facilitating the administrative coordination of patient care among health providers, dialysis providers, health plan sponsors, health facilities, pharmacies for medication management, physicians for disease management and psychosocial support, with a particular focus on patients with kidney disease
General Information
| Serial Number | 90586801 |
| Word Mark | CVS KIDNEY CARE RXREVIEW |
| Filing Date | Thursday, March 18, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, February 20, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 23, 2021 |
Trademark Statements
| Pseudo Mark | CONSUMER VALUE STORE KIDNEY CARE RX REVIEW |
| Goods and Services | pharmaceutical cost management services and drug utilization review services for patients with complex or chronic medical conditions; providing healthcare operations management services for healthcare providers, namely, facilitating the administrative coordination of patient care among health providers, dialysis providers, health plan sponsors, health facilities, pharmacies for medication management, physicians for disease management and psychosocial support, with a particular focus on patients with kidney disease |
| Disclaimer with Predetermined Text | "KIDNEY CARE RX REVIEW" |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, June 20, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CVS Pharmacy, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Woonsocket, RI 02895 |
| Party Name | CVS Pharmacy, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woonsocket, RI 02895 |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 21, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, February 20, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, June 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 14, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 14, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, June 14, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, January 18, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 23, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, October 15, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 15, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 15, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, October 15, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 15, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, October 7, 2021 | ASSIGNED TO EXAMINER |
| Sunday, June 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 22, 2021 | NEW APPLICATION ENTERED |
